Pds biotech leadership to present at 2025 cagla neauxcancer conference

Princeton, n.j., march 25, 2025 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb) (“pds biotech” or the “company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that frank bedu-addo, phd, president and chief executive officer of pds biotech, will present at the 2025 cancer advocacy group of louisiana (cagla) neauxcancer conference in new orleans on friday, march 28 – saturday, march 29, 2025.
PDSB Ratings Summary
PDSB Quant Ranking